PremiumCompany AnnouncementsEnovis Corporation Reports Strong Sales Growth Amid Challenges Enovis Positioned for Growth: Buy Rating Backed by Strong Sales, Product Launches, and Attractive Valuation Enovis: Strong Financial Performance and Growth Potential Justify Buy Rating PremiumPre-EarningsENOV Earnings Report this Week: Is It a Buy, Ahead of Earnings? Needham medtech & diagnostics analyst holds analyst/industry conference call Enovis Highlights Growth at J.P. Morgan Conference PremiumThe FlyTreace Medical announces Guy Guglielmino as chief commercial officer Enovis Corporation Reports Strong Sales Growth in Q3 2024 Morning Movers: CVS Health surges and ODP sinks following Q3 results